Revenue increased 11% to HUF 465.5 bln. Operating profit also rose 11% to HUF 140.4 bln.
Net income slipped 13% to HUF 120 bln as net financial income fell to HUF 3.2 bln from HUF 24.2 bln in the base period.
The United States was Richter’s biggest market in H1, generating turnover of HUF 127.9 bln, up 12%. Royalties from sales of Vraylar, the brand name there for Richter’s antipsychotic Cariprazine came to HUF 116.7 bln.
Revenue in Russia climbed 26% to HUF 74.4 bln and domestic turnover increased 5% to HUF 30.3 bln.
Cariprazine was the best-selling product during the period, bringing in HUF 124.4 bln. Runner-up was Richter’s transdermal contraceptive patch Evra, generating sales of HUF 17.8 bln.
“With a robust Q2 we are now tracking in line with our annual guidance despite the strong base,” CEO Gábor Orbán said.
At a press conference after the release of the report, Orbán noted that management expected full-year revenue, cleared of exchange rate effects, and operating profit, adjusted for one-offs, to climb around 10% in 2025.
He highlighted a 12.9% increase in revenue from women’s healthcare products, to HUF 168.8 bln, in H1, while turnover of generic products rose 7.7% to HUF 130 bln. R&D spending relative to revenue stood at 11% in H1, he added.
Orbán said there were no plans to announce new acquisitions in 2025, but Richter remained on the lookout for potential targets.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
